Showing 141 - 160 results of 173 for search '"Block B"', query time: 0.15s Refine Results
  1. 141
  2. 142

    Correlates and impacts of human-mammal conflict in the central part of Chitwan Annapurna Landscape, Nepal by Jagan Nath Adhikari, Bishnu Prasad Bhattarai, Tej Bahadur Thapa

    Published 2024-02-01
    “…The chital was the most abundant mammal (encounter rate (ER) = 1.49 and relative abundance (RA) = 55.45%) in block A whereas muntjac had the highest encounter rate in blocks B, C and D (ER = 0.34, 0.31, 0.79 respectively) but the relative abundance of rhesus was comparatively higher in blocks B, C and D. …”
    Get full text
    Article
  3. 143

    New treatment for non-Hodgkin B-cell lymphomas with a special focus on the impact of junctional adhesion molecules by Beat A. Imhof, Thomas Matthes

    Published 2017-09-01
    “…One such target is JAM-C, a molecule implicated in cell adhesion and in B cell migration and whose inhibition blocks B cells from reaching their supportive microenvironments in lymphoid organs. …”
    Get full text
    Article
  4. 144

    Dual Role of B Cells in Multiple Sclerosis by Gaurav Kumar, Robert C. Axtell

    Published 2023-01-01
    “…Yet, atacicept treatment, which blocks B-cell Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL), two cytokines important for B cell development and function, paradoxically increases disease activity in MS patients. …”
    Get full text
    Article
  5. 145

    Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies by Gihoon You, Jonghwa Won, Yangsoon Lee, Dain Moon, Yunji Park, Sang Hoon Lee, Seung-Woo Lee

    Published 2021-07-01
    “…Following the clinical success of cancer immunotherapies such as immune checkpoint inhibitors blocking B7/CTLA-4 or PD-1/PD-L1 signaling and ongoing numerous combination therapies in the clinic,3 bispecific antibodies (BsAbs) are now emerging as a growing class of immunotherapies with the potential to improve clinical efficacy and safety further. …”
    Get full text
    Article
  6. 146

    Theoretical study : analysis of automated flow lines using discrete-event simulation by Ali, Nor Azizah

    Published 2003
    “…The key parameters chosen are cycle time (T,), frequency of line stop per cycle (F), actual production time (T,), average hourly production rate (R,), average blocked (B,,), total hours of downtime (D), and line efficiency (E). …”
    Get full text
    Thesis
  7. 147

    Influence of Oligopeptide Length and Distribution on Polyisoprene Properties by Chang-Cheng Wang, Rong Zhang, Shiqi Li, Guangsu Huang, Maozhu Tang, Yun-Xiang Xu

    Published 2021-12-01
    “…In detail, a series of peptide-functionalized polyisoprenes with terminal blocks (B-2A-PIP, B-3A-PIP) or random sequences (R-2A-PIP, R-3A-PIP) are fabricated by using dipeptides (2A) or tripeptides (3A) as crosslinkers to explore the mechanism of terminal interaction on mechanism properties and chain dynamics. …”
    Get full text
    Article
  8. 148

    Protein requirement for Trichogaster lalius, blue variety by Jener Alexandre Sampaio Zuanon, Antonio Policarpo Souza Carneiro, Lidiane da Silva Nascimento, Donizete Aparecido da Silva, Marcelo Duarte Pontes, Márcio Yoshiyuki Kanashiro, Ana Lúcia Salaro

    Published 2013-02-01
    “…The experimental design was of randomised blocks (B1 = initial weight of 1.04±0.05 g and B2 = 1.36±0.02 g), with two replicates within each block and five treatments (230, 270, 310, 350 and 390 g CP/kg diet). …”
    Get full text
    Article
  9. 149

    Antioxidant, Anti-Inflammatory, Antimicrobial, and Anticancer Activities of Pomegranate Juice Concentrate by Hosam M. Habib, Hamada El-Gendi, Esmail M. El-Fakharany, Mohamed G. El-Ziney, Ahmed F. El-Yazbi, Fatima T. Al Meqbaali, Wissam H. Ibrahim

    Published 2023-06-01
    “…Additionally, PJC demonstrated potent antibacterial effects against human pathogens such as <i>Streptococcus mutans</i> and <i>Aeromonas hydrophila</i> and dose-dependently reduced the proliferation of colorectal, breast, and hepatic cancer cells via apoptosis. Furthermore, PJC blocked B-cell lymphoma 2 (BCl-2) and the expression of a potent cyclin-dependent kinase inhibitor (P21) and enhanced tumor protein (P53) expression, compared to both untreated cells and cells treated with fluoropyrimidine 5-fluorouracil (5-FU). …”
    Get full text
    Article
  10. 150

    In Situ Supramolecular Gel Formed by Cyclohexane Diamine with Aldehyde Derivative by Jae-Hyeon Park, Min-Hye Kim, Moo-Lyong Seo, Ji-Ha Lee, Jong-Hwa Jung

    Published 2022-01-01
    “…A mixture of building blocks <b>1</b> and <b>2</b> in various organic solvents, dichloromethane, tetrahydrofuran, chloroform, toluene, and 1,4-dioxane, resulted in the stable formation of supramolecular gel at room temperature within 60–100 s. …”
    Get full text
    Article
  11. 151

    B cells targeting therapy in the management of systemic lupus erythematosus by Wen Shi Lee, Olga Amengual

    Published 2020-01-01
    “…Several biologics that modulate B cells, either depleting B cells or blocking B cell functions, have been developed and evaluated in clinical trials. …”
    Get full text
    Article
  12. 152

    Laparoscopic Surgery: A Systematic Review of Loop and Knot Security, Varying with the Suture and Sequences, Throws, Rotation and Destabilization of Half-Knots or Half-Hitches by Philippe R. Koninckx, Anastasia Ussia, Arnaud Wattiez, William Kondo, Armando Romeo

    Published 2023-09-01
    “…Surgical knots are sequences of half-knots (H) or half-hitches (S), defined by their number of throws, by an opposite or similar rotation compared with the previous one, and for half-hitches whether they are sliding (s) or blocking (b). Opposite rotation results in (more secure) symmetric (s) knots, similar rotation in asymmetric (a) knots, and changing the active and passive ends has the same effect as changing the rotation. …”
    Get full text
    Article
  13. 153

    Contextual Interference Effect Is Independent of Retroactive Inhibition but Variable Practice Is Not Always Beneficial by Benjamin Thürer, Benjamin Thürer, Sarah Gedemer, Anne Focke, Thorsten Stein

    Published 2019-05-01
    “…Subjects practiced the force fields in either a Blocked (B), Random (R), or Constant (C) schedule. In addition, subjects of the Blocked group performed either a retest schedule that did (Blocked-Matched; BM) or did not (Blocked-Unmatched; BU) control for retroactive inhibition. …”
    Get full text
    Article
  14. 154

    Paeonol oxime inhibits bFGF-induced angiogenesis and reduces VEGF levels in fibrosarcoma cells. by Hyo-Jeong Lee, Seung-Ae Kim, Hyo-Jung Lee, Soo-Jin Jeong, Ihn Han, Ji Hoon Jung, Eun-Ok Lee, Shudong Zhu, Chang-Yan Chen, Sung-Hoon Kim

    Published 2010-01-01
    “…The treatment with PO blocked bFGF-stimulated migration and in vitro capillary differentiation (tube formation) in a dose-dependent manner. …”
    Get full text
    Article
  15. 155

    Nematode Assemblages Development Twenty-One Years after the Introduction of Meadow Soil into Bare Post Mining Spoil Heap by Petra Benetková, Ladislav Háněl, Jan Frouz

    Published 2022-07-01
    “…The soil samples were taken at the beginning of the experiment (1997) and then, after 19 years (2016), were transported into blocks (B) in their surroundings in a 2 m distance (I) and, finally, 30 m from the transported blocks as a control (C), to compare and assess the complexity of soil food web. …”
    Get full text
    Article
  16. 156

    Uptake of Biotinylated Spermine in Astrocytes: Effect of Cx43 siRNA, HIV-Tat Protein and Polyamine Transport Inhibitor on Polyamine Uptake by Christian J. Malpica-Nieves, Yomarie Rivera, David E. Rivera-Aponte, Otto Phanstiel, Rüdiger W. Veh, Misty J. Eaton, Serguei N. Skatchkov

    Published 2021-08-01
    “…Using a novel polyamine transport inhibitor (PTI), trimer 44NMe, we blocked b-SPM uptake, showing that PA uptake is via a PTI-sensitive transport mechanism such as organic cation transporter. …”
    Get full text
    Article
  17. 157

    Structural Motifs in Aryl Organogermanium Ge-O Derivatives for Material Design by Kirill V. Zaitsev, Igor S. Makarov, Yuri F. Oprunenko, Victor A. Tafeenko, Elmira Kh. Lermontova, Andrei V. Churakov

    Published 2023-09-01
    “…The structural types of these compounds were considered, providing 11 blocks (<b>A</b>–<b>K</b>). The molecular structures of the novel compounds [(<i>p</i>-FC<sub>6</sub>H<sub>4</sub>)<sub>3</sub>Ge]<sub>2</sub>O (<b>1</b>), [(<i>p</i>-F<sub>3</sub>CC<sub>6</sub>H<sub>4</sub>)<sub>3</sub>Ge]<sub>2</sub>O (<b>2</b>), and <i>cyclo</i>-[(<i>p</i>-F<sub>3</sub>CC<sub>6</sub>H<sub>4</sub>)<sub>2</sub>GeO]<sub>4</sub> (<b>3</b>) were studied through XRD (X-ray diffraction) analysis. …”
    Get full text
    Article
  18. 158

    A Versatile Brij-Linker for One-Step Preparation of Targeted Nanoparticles by Maria Anzengruber, Lisa Marie Nepustil, Fatlinda Kurtaj, Ammar Tahir, Katharina Skoll, Haider Sami, Michael Wirth, Franz Gabor

    Published 2023-05-01
    “…Moreover, the targeting ligand density and thus the cell association of the nanoparticles is easily fine-tuned by selection of the initial ratio of the building blocks. <b>Conclusions</b>: This strategy might be a first step towards the one-step preparation of nanoparticles with tailored functionalities. …”
    Get full text
    Article
  19. 159

    Novel Targeted Therapies for Rheumatoid Arthritis Based on Intracellular Signalling and Immunometabolic Changes: A Narrative Review by Marveh Rahmati, Maria Paula Kwesiga, Jiachen Lou, Ai Lyn Tan, Michael F McDermott

    Published 2024-01-01
    “…For example, rituximab therapy blocks B cell activation and abatacept effectively blocks T cell activation in patients with RA. …”
    Get full text
    Article
  20. 160

    Synthesis and Anti-Inflammatory Evaluation of a Library of Chiral Derivatives of Xanthones Conjugated with Proteinogenic Amino Acids by Sara F. Vieira, Joana Araújo, Virgínia M. F. Gonçalves, Carla Fernandes, Madalena Pinto, Helena Ferreira, Nuno M. Neves, Maria Elizabeth Tiritan

    Published 2023-06-01
    “…Herein, the synthesis of a library of CDXs is described, by coupling a carboxyxanthone (<b>1</b>) with both enantiomers of proteinogenic amino esters as chiral building blocks (<b>2</b>–<b>31</b>), following the chiral pool strategy. …”
    Get full text
    Article